Helena C van Doorn

university medical center rotterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Maaike van der Aa

Netherlands Comprehensive Cancer Organisation

NETHERLANDS

View details

Folkert J. van Kemenade

Erasmus University Rotterdam

NETHERLANDS

View details

Bernadette Heemskerk-Gerritsen

Erasmus MC Cancer Institute

NETHERLANDS

View details

eleonora van dorst

senior lecturer and honorary consultant

University Medical Center Utrecht, Utrecht University

NETHERLANDS

View details

Heleen J van Beekhuizen

Erasmus University Rotterdam

NETHERLANDS

View details

Caroline Muntinga

University of Maastricht

NETHERLANDS

View details

Geert J L H van Leenders

NETHERLANDS

View details

Anna Reyners

Professor in Palliative Medicine

University Medical Center Groningen

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Helena C van Doorn

Research Interests

Explore related searches

Contact this professor

Articles (10)

Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study

Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial

Hormone replacement therapy in women with iatrogenic premature ovarian insufficiency after radiotherapy for cervical cancer: A retrospective cohort and survey study

APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma—a multicenter, single-arm, phase II, clinical proof-of-concept study

Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy

Urinary incontinence more than 15 years after premenopausal risk‐reducing salpingo‐oophorectomy: a multicentre cross‐sectional study

Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients

Pelvic lymph node dissection for cervical or bladder cancer

Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors

Collaborators (8)

Maaike van der Aa

Folkert J. van Kemenade

Bernadette Heemskerk-Gerritsen

eleonora van dorst

Heleen J van Beekhuizen

Caroline Muntinga

Geert J L H van Leenders

Anna Reyners

Make your next move.